Literature DB >> 29931806

The polypeptide N-acetylgalactosaminyltransferase 4 exhibits stage-dependent expression in colorectal cancer and affects tumorigenesis, invasion and differentiation.

Xialin Yan1,2, Jishun Lu2, Xia Zou2, Sen Zhang1,2, Yalu Cui2, Leqi Zhou1,2, Feng Liu2, Aidong Shan2, Jiaoyang Lu1, Minghua Zheng1, Bo Feng1, Yan Zhang2.   

Abstract

The aberrant expression of mucin-type O-glycosylation plays important roles in cancer malignancy. The polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-Ts) are a family of conserved enzymes that initiate the mucin-type O-glycosylation in cells. In human, consistent up- or down-regulation of ppGalNAc-Ts expression during cancer development has been frequently reported. Here, we provide evidence that ppGalNAc-T4 shows a stage-dependent expression at the different stages of colorectal cancer (CRC) in the 62 pair-matched tumor/normal tissues. In detail, ppGalNAc-T4 expression is significantly induced at stage I and II but not at stage III and IV. Overexpression of ppGalNAc-T4 in CRC cells enhances colony formation and sphere formation suggesting an important role of ppGalNAc-T4 in tumorigenesis. Conversely, knockdown of ppGalNAc-T4 in CRC cells increases the cell migration and invasion, and leads to an epithelial-mesenchymal transition-like transition. Further analysis suggests that loss of ppGalNAc-T4 contributes to the dedifferentiation of CRC and high expression of ppGalNAc-T4 correlates to a good prognosis of patients. Taken together, our results not only demonstrate a stage-dependent expression of ppGalNAc-T4 in CRC progression, but also suggest that such stage-dependent expression may contribute to the tumorigenesis at the early stage and promote cell migration and invasion at the advanced stage.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  O-glycosylation; colorectal cancer; glycosyltransferase; ppGalNAc-T4; stage-dependent expression

Mesh:

Substances:

Year:  2018        PMID: 29931806     DOI: 10.1111/febs.14593

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  3 in total

1.  ppGalNAc-T4-catalyzed O-Glycosylation of TGF-β type Ⅱ receptor regulates breast cancer cells metastasis potential.

Authors:  Qiong Wu; Cheng Zhang; Keren Zhang; Qiushi Chen; Sijin Wu; Huang Huang; Tianmiao Huang; Nana Zhang; Xue Wang; Wenli Li; Yubo Liu; Jianing Zhang
Journal:  J Biol Chem       Date:  2020-12-03       Impact factor: 5.157

2.  Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway.

Authors:  Bin-Bin Zhang; Lu Gao; Qin Yang; Yuan Liu; Xiao-Yue Yu; Ji-Hong Shen; Wen-Cai Zhang; Zhan-Ying Han; Shao-Ze Chen; Sen Guo
Journal:  Cell Death Dis       Date:  2021-10-22       Impact factor: 8.469

3.  Glycomic Signatures of Plasma IgG Improve Preoperative Prediction of the Invasiveness of Small Lung Nodules.

Authors:  Xia Zou; Feng Yao; Fang Yang; Fang Zhang; Zhijue Xu; Jingjing Shi; Atsushi Kuno; Heng Zhao; Yan Zhang
Journal:  Molecules       Date:  2019-12-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.